This site is intended for health professionals only

NICE approves QOF target for statin prescribing in type 1 diabetes

NICE has given the go-ahead to two new QOF indicators that will reward GP practices for treating diabetes patients, including one incentivising statins.

The indicators – decided at NICE’s indicator advisory committee meeting today – will see QOF points awarded to practices for how many diabetes patients they treat to a target Hba1c of 58mmol/mol or less, marginally lower than the current QOF target of 59mmol/mol. 

GPs will also be incentivised to give statins to patients with type 1 diabetes who are aged over 40 and have had either diabetes for more than 10 years or who have other risk factors for CVD. 

Article continues below this sponsored advert

But plans to introduce a new QOF indicator for a target Hba1c of 53mmol/mol were rejected, after GP members of the panel voiced their concerns that it could pose a threat to patient safety, with older people especially being at risk to over-treatment and adverse events.

It follows NICE’s latest guidance for type 2 diabetes that were published earlier this year and recommended that GPs take a more individual-based approach for targets, especially in the elderly and those with poor hypoglycaemic control. 

The indicators were part of a raft of new proposed recommendations discussed at the meeting by NICE specialists as well as GP members. Their actual implementation is subject to negotiation with the profession.


Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.